109 related articles for article (PubMed ID: 6877542)
21. A model for research on the blood-brain barrier disruption induced by unsaturated fatty acid emulsion.
Kim HJ; Pyeun YS; Kim YW; Cho BM; Lee TH; Moon TY; Suh KT; Park BR
Invest Radiol; 2005 May; 40(5):270-6. PubMed ID: 15829824
[TBL] [Abstract][Full Text] [Related]
22. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
23. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies.
Cosolo WC; Martinello P; Louis WJ; Christophidis N
Am J Physiol; 1989 Feb; 256(2 Pt 2):R443-7. PubMed ID: 2492773
[TBL] [Abstract][Full Text] [Related]
24. The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood-brain barrier disruption.
Bhattacharjee AK; Nagashima T; Kondoh T; Tamaki N
Brain Res; 2001 May; 900(2):157-62. PubMed ID: 11334793
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
26. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
[TBL] [Abstract][Full Text] [Related]
27. Intracarotid tumor necrosis factor-alpha administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis.
Abraham CS; Deli MA; Joo F; Megyeri P; Torpier G
Neurosci Lett; 1996 Apr; 208(2):85-8. PubMed ID: 8859896
[TBL] [Abstract][Full Text] [Related]
28. Micro-SPECT/CT-based pharmacokinetic analysis of 99mTc-diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound.
Yang FY; Wang HE; Lin GL; Teng MC; Lin HH; Wong TT; Liu RS
J Nucl Med; 2011 Mar; 52(3):478-84. PubMed ID: 21321259
[TBL] [Abstract][Full Text] [Related]
29. Effect of intracarotid infusion of etoposide with angiotensin II-induced hypertension on the blood-brain barrier and the brain tissue.
Ogasawara H; Kiya K; Kurisu K; Hotta T; Mikami T; Sugiyama K; Nakahara T; Uozumi T
J Neurooncol; 1992 Jun; 13(2):111-7. PubMed ID: 1432030
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
31. Neurotoxicity after intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea administration in the rat: hemodynamic changes studied by double-tracer autoradiography.
Nagahiro S; Yamamoto YL; Diksic M; Mitsuka S; Sugimoto S; Feindel W
Neurosurgery; 1991 Jul; 29(1):19-25; discussion 26. PubMed ID: 1870683
[TBL] [Abstract][Full Text] [Related]
32. [Blood-brain barrier opening microcirculation in human brain tumor].
Sato S; Toya S; Otani M
No To Shinkei; 1985 Feb; 37(2):109-13. PubMed ID: 2988587
[TBL] [Abstract][Full Text] [Related]
33. Quantification of early blood-brain barrier disruption by in situ brain perfusion technique.
Bhattacharjee AK; Nagashima T; Kondoh T; Tamaki N
Brain Res Brain Res Protoc; 2001 Oct; 8(2):126-31. PubMed ID: 11673094
[TBL] [Abstract][Full Text] [Related]
34. Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog.
Neuwelt EA; Frenkel EP; Rapoport S; Barnett P
Neurosurgery; 1980 Jul; 7(1):36-43. PubMed ID: 6774280
[TBL] [Abstract][Full Text] [Related]
35. Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase.
Kaya M; Ahishali B
Methods Mol Biol; 2011; 763():369-82. PubMed ID: 21874465
[TBL] [Abstract][Full Text] [Related]
36. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
[TBL] [Abstract][Full Text] [Related]
37. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer LK; Oldfield EH
J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
[TBL] [Abstract][Full Text] [Related]
38. WR-2721 entry into the brain across a modified blood-brain barrier.
Lamperti A; Conger AD; Jenkins O; Cohen G; Rizzo A; Davis ME; Sodicoff M
Radiat Res; 1988 Aug; 115(2):303-13. PubMed ID: 2841714
[TBL] [Abstract][Full Text] [Related]
39. [The effect of Gd-DTPA on magnetic resonance imaging: a potential blood-brain barrier indicator].
Hashimoto K; Yamagata S; Minamikawa J; Watanabe Y; Kanesiro M; Kikuchi H
No To Shinkei; 1988 May; 40(5):461-6. PubMed ID: 3415864
[TBL] [Abstract][Full Text] [Related]
40. Intra-carotid angiotensin II activates tyrosine hydroxylase-expressing rostral ventrolateral medulla neurons following blood-brain barrier disruption in rats.
Yao ST; May CN
Neuroscience; 2013 Aug; 245():148-56. PubMed ID: 23608099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
